Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00750256 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects
A Phase 1 study of Anaemia, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00750256 is a Phase 1 study of Anaemia that has completed, run by GlaxoSmithKline. The registered enrollment target is 36 participants, below the 64-participant average among 3 other Anaemia trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00750256, a Phase 1 study of Anaemia, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
A first-time in human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK1278863A in healthy subjects
Conditions Studied
Interventions
- DRUG GSK1278863A
Study Locations (1)
Indiana
- GSK Investigational Site - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-07-07 |
| Est. Completion | 2008-12-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00750256
The ClinicalTrials.gov registry entry for NCT00750256 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 64-participant average among 3 other Anaemia trials with a reported enrollment target (44% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anaemia appearing as the primary indexed condition, and to 1 intervention - of which GSK1278863A is the first listed.
NCT00750256 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00750256 about?
NCT00750256 is a clinical study titled "A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects". A first-time in human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK1278863A in healthy subjects
What is the current status of trial NCT00750256?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2008-07-07. Estimated completion is 2008-12-12.
What conditions does trial NCT00750256 study?
This clinical trial studies the following conditions: Anaemia.
What interventions are being tested in trial NCT00750256?
The interventions under investigation include: GSK1278863A (DRUG).
Who is sponsoring clinical trial NCT00750256?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00750256 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anaemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers
COMPLETED · Phase 1
-
Daprodustat Hepatic Impairment Study
COMPLETED · Phase 1
-
Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.